These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 1363672)

  • 41. The emerging problem of plasma lipid changes during antihypertensive therapy.
    Johnson BF
    J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S213-21. PubMed ID: 6177959
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Acute effects of beta-blocker with intrinsic sympathomimetic activity on stress-induced cardiac dysfunction in rats.
    Ishikura F; Takano Y; Ueyama T
    J Cardiol; 2012 Dec; 60(6):470-4. PubMed ID: 22898333
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Evaluation of myocardial relaxation in the treatment of arterial hypertension: vasodilators and beta blockers].
    Gimeno JV; Martín G; Cosín J
    Rev Esp Cardiol; 1985; 38(5):342-7. PubMed ID: 2867585
    [No Abstract]   [Full Text] [Related]  

  • 44. The impact of third-generation beta-blocker antihypertensive treatment on endothelial function and the prothrombotic state: effects of smoking.
    Vyssoulis GP; Marinakis AG; Aznaouridis KA; Karpanou EA; Arapogianni AN; Cokkinos DV; Stefanadis CI
    Am J Hypertens; 2004 Jul; 17(7):582-9. PubMed ID: 15233977
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Celiprolol--overview of 6 years of clinical trials experience.
    Pruss TP; Lamon KD; Hagen NS
    J Int Med Res; 1988; 16 Suppl 1():17A-22A. PubMed ID: 2906015
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A comparison of celiprolol and propranolol in the treatment of hypertension.
    Taylor S; Beattie A; Capone P
    Br J Clin Pract Suppl; 1985 Jun; 40():78-9. PubMed ID: 2864071
    [No Abstract]   [Full Text] [Related]  

  • 47. A comparison of celiprolol and atenolol in the treatment of hypertension.
    Rosenthal F; Silke B; Capone P
    Br J Clin Pract Suppl; 1985 Jun; 40():76-7. PubMed ID: 2864070
    [No Abstract]   [Full Text] [Related]  

  • 48. Plasma lipids during chronic antihypertensive therapy with different beta-blockers.
    Fogari R; Zoppi A; Pasotti C; Poletti L; Tettamanti F; Malamani G; Corradi L
    J Cardiovasc Pharmacol; 1989; 14 Suppl 7():S28-32. PubMed ID: 2481787
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Comparative biochemical analysis of blood serum lipoproteins from human and various animal species].
    Lizenko MV; Regerand TI; Bakhirev AM; Lizenko EI
    Zh Evol Biokhim Fiziol; 2008; 44(5):492-500. PubMed ID: 18959212
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Intrinsic sympathomimetic action and its special features as demonstrated by the beta-1-receptor blocker celiprolol].
    Pittner H
    Wien Klin Wochenschr Suppl; 1985; 162():1-21. PubMed ID: 2861698
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The use of the cardioselective adrenergic beta 1-blockader cordanum in the treatment of arterial hypertension].
    Zonis BIa; Brin VB
    Ter Arkh; 1983; 55(5):81-3. PubMed ID: 6137077
    [No Abstract]   [Full Text] [Related]  

  • 52. Celiprolol--new clinical perspectives beyond cardioselectivity. Proceedings of a symposium. Madrid, Spain, 24 January 1987.
    J Int Med Res; 1988; 16 Suppl 1():1A-80A. PubMed ID: 2906014
    [No Abstract]   [Full Text] [Related]  

  • 53. Beta blockers enhance early diastolic filling in ischaemic heart disease: a radionuclide assessment.
    Moralidis E; McCurrach G; Martin W; Hutton I
    Heart; 2001 Oct; 86(4):457. PubMed ID: 11559691
    [No Abstract]   [Full Text] [Related]  

  • 54. [Efficacy of beta-selective blocker with vasodilatating features celiprolol in patients with mild and moderate hypertension].
    Pogosova GV; Zhidko NI; Mikheeva TG; Gudkova OA; Tikhomirova EA
    Kardiologiia; 2003; 43(3):24-7. PubMed ID: 12913979
    [No Abstract]   [Full Text] [Related]  

  • 55. Effect of celiprolol and metoprolol on lipids, fibrinogen and airways function in hyperlipidaemic hypertensives: a randomised double-blind long-term parallel group trial.
    Johnston GD; Vyssoulis G; Feely J; Holden RD; Radley DR
    J Hum Hypertens; 1995 Feb; 9(2):123-9. PubMed ID: 7752174
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Adrenergic mechanisms and their significance for plasma lipid concentrations].
    Day JL
    Wien Med Wochenschr; 1982; 132 Spec No 2():19-22. PubMed ID: 6132497
    [No Abstract]   [Full Text] [Related]  

  • 57. [The third generation of b-blockers: new possibilities ].
    Iagenskiĭ AV; Barsukov BP
    Kardiologiia; 1992; 32(11-12):98-103. PubMed ID: 1363672
    [No Abstract]   [Full Text] [Related]  

  • 58. [Lipid lowering therapy in the treatment and secondary prevention of ischemic heart disease].
    Zimin IuV
    Kardiologiia; 2003; 43(4):74-83. PubMed ID: 12968608
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.